Biotech3 hours ago
Advances in LDL Cholesterol Management for Familial Hypercholesterolemia: From Statins to Innovative PCSK9 and CETP Inhibitors
PCSK9 inhibitors have transformed LDL cholesterol management in familial hypercholesterolemia, with new antibodies and CETP inhibitors like obicetrapib expanding options. Statins remain safe and effective, achieving...